Health For Each Health For Each
  • Cantor Global Healthcare
  • bone cancer cells
  • public health experts
  • Employees Health Benefits
  • Environmental Health
  • brain
  • KFF Health Information
  • Tirzepatide


    Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

    Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

    In a recent review and meta-analysis published in the International Journal of Obesity, researchers evaluated the safety and efficacy of once-weekly Tirzepatide, a revolutionary new anti-obesity and anti-diabetes drug, against conventional long- and ultra-long-acting insulin supplements in managing type 2 diabetes (T2D).